Meet The European VCs Investing in Biotech

Just a few months ago, in December 2025, the European Commission and EIB Group announced a new initiative to invest €10 billion into Europe’s biotech sector.

The project is designed to make Europe a bigger player in the global biotech industry, helping drive more investment into the discovery and development of new biotechnologies.

This is off the back of a huge jump in interest in the biotech sector over recent years. In fact, according to the BIA, the UK’s biotech sector raised £3.5 billion in 2024, up 94% from the previous year.

Across Europe, the level of funding in the sector hit a record €4.7 billion.

What Actually Is Biotech?

Biotechnology, or biotech, involves using or adapting living organisms for human benefit. This might be through genetic engineering, creating disease-resistant crops or developing new vaccines.

Ultimately, biotech leans on using existing biology to help improve the quality of life for people around the world.

Who Is Investing In Biotech?

But who exactly is investing in biotech? Here, we take a look at some of the European VCs that are backing biotech across Europe.

V-Bio Ventures

V-Bio Ventures is a venture capital firm based in Belgium that invests in early to mid stage biotech companies with high growth potential.

At its core, V-Bio looks to use scientific innovation to create products that positively impact people’s lives.

AdBio Partners

AdBio Partners is a French life-sciences VC firm that focuses on early stage biotech ventures across Europe.

The firm looks specifically for companies that are finding and developing breakthrough medical discoveries.

Sofinnova Partners

Sofinnova Partners is a European biotech VC firm that invests in early stage companies applying biotechnology to food, farming, chemicals and materials.

To date, Sofinnova Partners has invested in over 118 companies with over 55 IPOs and over 30 mergers and acquisitions. Based in Paris, the firm has been operating for over 50 years in the space.

Ysios Capital

Ysios Capital is a life sciences investor that backs biotech companies through a variety of funds.

Primarily, they invest in companies that have a positive impact on patients and society, and have invested in 42 private and public biotech companies to date.

Based in Spain, Ysios Capital is positioning themselves at the forefront of the biomedical revolution.

Nina Capital

Nina Capital is a VC firm based in Barcelona that invests in companies that sit at the intersection of healthcare and technology. Whilst Nina specifically doesn’t invest in drug or vaccine companies, they are looking for businesses that are data-driven.

Geographically, the firm invests in companies across Europe, the US, Israel, Canada and Australia with a focus on pre-seed to seed stage businesses.

Redalpine

Redalpine is a Zurich-based VC firm that looks to back companies across biotech, healthtech and ICT.

Specifically, they look for businesses that are setting out to use technology to tackle some of the world’s most pressing challenges, mixing software and science.

Bpifrance

bpifrance is the French sovereign wealth fund and public investment bank, designed to invest in companies that foster economic growth.

Currently, bpifrance has a number of biotech funds dedicated to funding ventures in the space. The funds include Innovio, Innobio 2, The Rare Diseases Fund, The Medtech innovation Fund and Patient Autonome.